DrugCite
Search

THIOCOLCHICOSIDE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Thiocolchicoside Adverse Events Reported to the FDA Over Time

How are Thiocolchicoside adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Thiocolchicoside, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Thiocolchicoside is flagged as the suspect drug causing the adverse event.

Most Common Thiocolchicoside Adverse Events Reported to the FDA

What are the most common Thiocolchicoside adverse events reported to the FDA?

Alanine Aminotransferase Increased
10 (3.33%)
Aspartate Aminotransferase Increase...
10 (3.33%)
Cytolytic Hepatitis
9 (3%)
Purpura
8 (2.67%)
Rash
8 (2.67%)
Vomiting
8 (2.67%)
Pruritus
7 (2.33%)
Back Pain
6 (2%)
Lipase Increased
6 (2%)
Rash Macular
6 (2%)
Coma
5 (1.67%)
Show More Show More
Dermatitis Bullous
5 (1.67%)
Hypotension
5 (1.67%)
Nausea
5 (1.67%)
Toxic Epidermal Necrolysis
5 (1.67%)
Aggression
4 (1.33%)
Blood Immunoglobulin E Increased
4 (1.33%)
Hyperhidrosis
4 (1.33%)
Mydriasis
4 (1.33%)
Rash Erythematous
4 (1.33%)
Suicide Attempt
4 (1.33%)
Transaminases Increased
4 (1.33%)
Constipation
3 (1%)
Coordination Abnormal
3 (1%)
Diarrhoea
3 (1%)
Dyspnoea
3 (1%)
Erythema
3 (1%)
Inflammation
3 (1%)
Injection Site Pain
3 (1%)
Injection Site Swelling
3 (1%)
Memory Impairment
3 (1%)
Pemphigoid
3 (1%)
Pyrexia
3 (1%)
Rectal Haemorrhage
3 (1%)
Renal Failure Acute
3 (1%)
Renal Impairment
3 (1%)
Urticaria
3 (1%)
Abdominal Pain
2 (.67%)
Abortion Spontaneous
2 (.67%)
Anaphylactic Reaction
2 (.67%)
Anaphylactic Shock
2 (.67%)
Anuria
2 (.67%)
Cough
2 (.67%)
Cyanosis
2 (.67%)
Drug Exposure During Pregnancy
2 (.67%)
Drug Interaction
2 (.67%)
Eczema
2 (.67%)
Face Oedema
2 (.67%)
Gait Disturbance
2 (.67%)
General Physical Health Deteriorati...
2 (.67%)
Hypoxia
2 (.67%)
Metabolic Acidosis
2 (.67%)
Mucosal Ulceration
2 (.67%)
Multi-organ Failure
2 (.67%)
Muscle Contractions Involuntary
2 (.67%)
Oedema Peripheral
2 (.67%)
Oliguria
2 (.67%)
Pain In Extremity
2 (.67%)
Pancreatitis
2 (.67%)
Pleural Effusion
2 (.67%)
Pneumococcal Sepsis
2 (.67%)
Purpura Non-thrombocytopenic
2 (.67%)
Sepsis
2 (.67%)
Skin Necrosis
2 (.67%)
Spinal Compression Fracture
2 (.67%)
Staphylococcal Sepsis
2 (.67%)
Stevens-johnson Syndrome
2 (.67%)
Tachypnoea
2 (.67%)
Toxic Skin Eruption
2 (.67%)
Wound
2 (.67%)
Abscess Bacterial
1 (.33%)
Agitation
1 (.33%)
Amnesia
1 (.33%)
Anaemia
1 (.33%)
Biliary Dilatation
1 (.33%)
Blood Alkaline Phosphatase Increase...
1 (.33%)
Blood Creatine Phosphokinase Increa...
1 (.33%)
Blood Glucose Increased
1 (.33%)
Body Temperature Increased
1 (.33%)
C-reactive Protein Increased
1 (.33%)
Cardiac Failure
1 (.33%)
Cheilitis
1 (.33%)
Computerised Tomogram Abnormal
1 (.33%)
Decreased Appetite
1 (.33%)
Dehydration
1 (.33%)
Drug Effect Decreased
1 (.33%)
Drug Rash With Eosinophilia And Sys...
1 (.33%)
Eosinophilia
1 (.33%)
Extradural Abscess
1 (.33%)
Feeling Hot
1 (.33%)
Gamma-glutamyltransferase Increased
1 (.33%)
Haematoma
1 (.33%)
Haemodialysis
1 (.33%)
Hyperaemia
1 (.33%)
Ill-defined Disorder
1 (.33%)
Induration
1 (.33%)
Injection Site Abscess
1 (.33%)
Injection Site Reaction
1 (.33%)
Intervertebral Disc Operation
1 (.33%)
Intervertebral Discitis
1 (.33%)
Leukocytosis
1 (.33%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Thiocolchicoside, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Thiocolchicoside is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Thiocolchicoside

What are the most common Thiocolchicoside adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Thiocolchicoside, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Thiocolchicoside is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Thiocolchicoside According to Those Reporting Adverse Events

Why are people taking Thiocolchicoside, according to those reporting adverse events to the FDA?

Back Pain
31
Arthralgia
6
Drug Use For Unknown Indication
4
Fibromyalgia
4
Product Used For Unknown Indication
4
Muscle Contracture
3
Show More Show More
Neck Pain
3
Periarthritis
3
Hip Fracture
2
Sciatica
2
Ill-defined Disorder
1
Musculoskeletal Pain
1
Myalgia
1
Osteoarthritis
1
Pain
1

Thiocolchicoside Case Reports

What Thiocolchicoside safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Thiocolchicoside. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Thiocolchicoside.